The $5.3 million sale of a precious rock from Mars belonging to Niger spurs outrage
A Martian meteorite weighing 24.6 kilograms and discovered in Niger was auctioned for $5.3 million at Sotheby's New York.
The meteorite, known as NWA 16788, is the largest Martian rock ever found on Earth, estimated to have traveled 140 million miles.
Concerns were raised about the legality and ethical implications of exporting this significant artifact from Niger.
In November 2023, a meteorite hunter discovered NWA 16788 in the Agadez area of northern Niger.
It weighs more than 24.6 kilograms (54 pounds) and is the biggest Martian rock ever recovered on Earth, according to Sotheby's.
Experts estimate it traveled 140 million miles from Mars' surface, likely dislodged by an ancient asteroid impact, before landing in the Sahara sands.
The auction started at $1.9 million and quickly jumped to $4.3 million, with premiums and fees bringing the total to $5.3 million.
However, Sotheby's has not revealed the identity of either the buyer or the seller, heightening speculation over how such an important alien item departed its nation of origin.
The auction took place during the auction house's "Geek Week," which features goods related to natural history, science, and space.
A private gallery in Tuscany, Italy, and the Italian Space Agency had both previously exhibited the rock.
Conversation on meteorites in Africa
The specimen's provenance remains a matter of debate, however, as reported by Forbes.
'The NWA 16788 meteorite was shipped and transported in line with the standard procedure of all meteorites that come out of Niger.
As with everything we sell, all relevant documentation was in order at each stage of its journey,' Sotheby's tells Forbes Africa.
According to Giovanni Pratesi, a professor at the University of Florence in Italy and one of the authors of two of the three papers referenced in the Sotheby's catalogue, he was 'only involved in the characterization and study of this specimen (NWA 16788), without having received, for a while, any information about provenance.'
'In fact, the place of recovery of the meteorites is not so important for science because their real provenance, of course, is not the Earth but other bodies of the Solar System,' Pratesi says.
'Anyway, there is no doubt that the Sahara represents a very important reservoir of extraterrestrial material.
'A confirmation of this is given by the high number of meteorite specimens bearing the name NWA (North West Africa) that is used when the exact place of recovery is not known.
In this respect, I believe that African countries should organize a network to recover and valorize these meteorites.'
The sale has reignited concerns about the unregulated trade of meteorites, particularly those discovered in developing countries.
Nigerien officials and international cultural watchdogs are now questioning the legality and ethics of the meteorite's export, with many demanding its immediate return.
'It was discovered in Niger? How come it ended up being sold in New York?' says Alia Baré, a fashion designer and daughter of former Nigerien president Ibrahim Baré Maïnassara, to Forbes Africa.
'It is a crucial matter of sovereignty… This is a national treasure that shouldn't have been sold. Things have to change,' she added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
NASA explains how it keeps the Curiosity rover running, 13 years later
Thirteen years ago, the Curiosity rover landed on Mars, inside Gale crater in particular. It was originally sent to the red planet for a two-year mission, but it was extended indefinitely just a few months into its operations. The rover has several goals, most of which are meant to help scientists determine whether Mars could ever have supported life in the past. And while it's still very much operational and doing science, NASA has had to make adjustments and give it new capabilities to ensure that it can keep running. In a new post celebrating the 13th anniversary of the rover's landing, NASA's Jet Propulsion Laboratory has detailed the updates the Curiosity team has had to implement. To start with, the team manages the rover's daily power budget with great care to make sure it can do its job and last longer. See, Curiosity uses a power system called Multi-Mission Radioisotope Thermoelectric Generator (MMRTG), which relies on decaying plutonium pellets to generate energy. As the plutonium decays over time, it takes longer and longer for the system to recharge the rover's battery. That's why the team now meticulously factors in every device that draws on the batteries. They consolidate Curiosity's tasks to shorten the time the rover is active to also reduce the energy used. The ground team, for instance, tells Curiosity to talk to an orbiter while driving or moving its robotic arm instead of doing one task at a time. If the rover finishes its tasks early, it can go to sleep early and recharge for the next day, which JPL says maximizes the life of the MMRTG. Over the past years, NASA has also rolled out updates to change how the rover's robotic arm drill collects samples and to improve its driving capabilities. JPL developed an algorithm to reduce wear on the rover's wheels, as well, so they can last longer. From the time Curiosity had landed on Mars, it has provided us with multiple discoveries and new information. It discovered organic molecules in Martian atmosphere and soil, detected "startlingly high" levels of methane that's a gas typically produced by life as we know it, and it found evidence of ancient megafloods on the red planet. And water, as you know, could indicate the presence of life.
Medscape
3 hours ago
- Medscape
Myths About Influenza Vaccination Debunked
I have written a lot about health myths that many of us as health professionals believe. Here, I'd like to address some myths about influenza shots that our patients believe. 'I do not want the flu shot, since it will make me sick or give me the flu.' This is a common reason patients will share as to why they do not want a flu shot. Frequently, I will hear about the time they did get a flu shot and shortly afterward got sick. This myth has been well studied with well-designed trials. Govaert and colleagues studied more than 1800 patients over the age of 60 who were randomly assigned to receive flu vaccine or placebo saline injection; side effects were tracked over 4 weeks. The only difference in side effects was an increased rate of local tenderness at the injection site: 17.5% in the vaccine group vs 7.3% in placebo group. There was no significant difference in systemic side effects. Douglas S. Paauw, MD Margolis et al conducted a randomized, controlled, crossover trial in 336 veterans aged 65 or older. Trial participants were randomly assigned to receive influenza vaccine followed 2 weeks later by placebo injection or placebo followed 2 weeks later by vaccine. The only significant difference after receiving vaccine compared with placebo was a sore arm. There was no difference in any other symptom. Another interesting study looked at patients with chronic obstructive pulmonary disease who received influenza vaccine or placebo; side effects and respiratory infections were evaluated in the first week after vaccination. Local adverse reactions were noted in 27% of the vaccine group and 6% of the placebo group (P =.002). No significant difference in systemic adverse reactions was measured between the vaccine and placebo groups, and there was no difference observed in the incidence of acute respiratory infections between the vaccine and placebo groups during the first week (6.4% vs 6.3%; P = 1.0) and the first 4 weeks (24.2% vs 31.7%; P =.5) after vaccination. 'I can't get the flu shot because I am allergic to eggs.' For many years, patients were asked if they had an egg allergy, and if they did, they usually were told not to get influenza vaccine. This was because of the concern that potentially minute particles of egg protein could contaminate the vaccine and individuals with severe allergy could have a bad reaction. Turner and colleagues recruited 779 young people (2-18 years) with egg allergy to receive influenza vaccine. The cohort included 270 young people with previous anaphylaxis to egg. No systemic allergic reactions occurred in any participants. Kelso reviewed 28 studies with a total of 4315 patients with egg allergy who received egg-based Influenza vaccine: included were 656 patients with a history of anaphylaxis to egg. None of these patients developed a serious reaction when they received influenza vaccine. A 2017 joint practice parameter by the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology stated that all patients with egg allergy of any severity should receive inactivated influenza vaccine annually, using any age-approved brand, and there are no special waiting periods after vaccination of egg allergic patients beyond what is standard practice for any vaccine. Pearl: Influenza vaccine can cause local discomfort but is no different from placebo in producing systemic symptoms. Individuals with a history of egg allergy can safely receive any form of influenza vaccine.
Medscape
9 hours ago
- Medscape
Steroid Abuse Withdrawal Symptoms Tied to Psychiatric Burden
San Francisco — The sexual dysfunction and depression commonly seen in men following withdrawal from anabolic steroid abuse are more closely tied to psychiatric burden than to hormonal levels, new research suggests. 'Psychiatric burden was the only factor found to be independently associated with these symptoms, and no association with hormonal levels. This highlights the importance of psychological interventions in the management of men wishing to cease androgen abuse,' Bonnie Grant, MD, a clinical research fellow at Imperial College London, London, England, said at ENDO 2025: The Endocrine Society Annual Meeting. Androgen abuse is 'a growing, global problem,' she said, noting that about 6.4% of men worldwide abuse anabolic steroids, increasing up to 20% in recreational gym users. The primary motivations are image and muscular enhancement. However, the practice confers a threefold higher mortality rate, predominantly from cardiac conditions such as cardiomyopathy, or from suicide. Few studies have examined the effects of stopping steroid use, which precipitates a rapid drop in testosterone levels. 'We have noticed through our clinical experience that often these men, when they stop, report a lot of symptoms. They feel very depressed. They feel like they've lost their sexual function. We wanted to know what predicts that,' Grant told Medscape Medical News . Psychiatric Comorbidity, Not Hormonal Levels, Linked to Steroid Withdrawal In their cross-sectional, observational study, Grant and colleagues recruited men from four sites in the UK, where personal nonprescription use of anabolic steroids is legal. They were divided into three groups: 50 nonusers of anabolic steroids, 125 current users, and 90 who had stopped using within the past year. 'We focused on the first year, as this has been shown to be a time period with high rates of relapse, often due to the severity of withdrawal symptoms,' Grant explained. The men had an average age of about 36.5 years. In the past user group, the average time since quitting was 4.5 months. At a single study visit, the participants all completed several questionnaires: one on androgen use, the International Index Erectile Function-15 (IIEF-15) for sexual function, the Beck Depression Inventory-II (BDI-II) for depression, Generalized Anxiety Disorder-7 for anxiety, and Short-Form-36 for quality of life. They also underwent fasted, morning blood testing with urine toxicology to verify claims of noncurrent use. Men in the current and past anabolic steroid use groups had significantly higher rates of psychiatric comorbidity, mainly depression and anxiety (27.2% of the current users and 24.4% of the past users vs 10.0% of the nonusers; P = .038). The use of illicit drugs, mainly cocaine and cannabis, was also greater in the current and past users (43.2% current and 47.7% past vs 22% nonusers; P = .007). As expected, men with current use had significantly higher total testosterone levels, with a mean of 72.2 nmol/L compared with 14.3 nmol/L in the past users and 20.6 nmol/L in the nonusers ( P < .001). The latter two did not differ significantly. Levels of luteinizing hormone and follicle-stimulating hormone were fully suppressed in the current users but had recovered in the past use group ( P < .001 for both). Men with past androgen abuse had significantly lower scores on the IIEF-15, indicating worse sexual function compared with the other two groups. Among past users, a total testosterone < 8 nmol/L had a positive predictive value (PPV) for sexual dysfunction of 73%, indicating that hypogonadism was relatively predictive of sexual dysfunction. However, the negative predictive value (NPV) was 48%, suggesting that a total testosterone level above this threshold does not reliably exclude sexual dysfunction, Grant said. Looking at mood symptoms, the past use group had significantly higher scores on the BDI-II, indicating worse mood symptoms. Testosterone levels did not correlate with BDI scores. In the past users, total testosterone < 8 nmol/L poorly predicted moderate-to-severe depression (PPV, 20%), although the NPV was higher (81%). In multivariate analysis, psychiatric comorbidity was the only independent predictor of symptoms among men who had quit abusing anabolic steroids in the past year ( P = .01 for sexual dysfunction; P < .0001 for mood disorders). Total testosterone levels were not independently associated with symptom scores. 'A Window of Opportunity' Asked to comment, session moderator Shalender Bhasin, MD, director of the Research Program in Men's Health: Aging and Metabolism at Brigham and Women's Hospital, Boston, pointed out that in addition to depression and anxiety, these men will often have other psychiatric conditions, including body image disorder. 'Anabolic steroid use has not become a national priority, and I think it should be, because we have seen an underground, invisible epidemic of body image disorders and anabolic steroid use,' he told Medscape Medical News . 'People say, 'well, where are the dead bodies?' The thing is that these are gateway drugs, and we are seeing high rates of suicides, and other mental health problems in young men. The tragedy is that the [National Institutes of Health] and academia have done little to deal with this growing societal problem, mostly among young men. It is equally important to address the co-occurring psychopathology as it is to treat the withdrawal symptoms,' he said. Bhasin, who is also professor of medicine at Harvard Medical School, Boston, added that when men try to quit anabolic steroid use, the severity of the withdrawal symptoms often leads to relapse, and a 'vicious cycle of [anabolic-androgenic steroid (AAS] use, withdrawal, and relapse. For this reason, AAS withdrawal hypogonadism needs to be managed carefully medically. This also offers a window of opportunity when the patients undergoing withdrawal may be amenable to getting off AAS use altogether.' Grant received a speaker's honorarium from Besins Healthcare. Bhasin reported receiving research grant support from AbbVie and Metro International Biotech for investigator-initiated research, with the grants managed by Brigham and Women's Hospital. He had served as a consultant to Besins and Versanis and has an equity interest in XYone Therapeutics.
